Skip to main content
. 2014 Sep;6(9):1239–1250. doi: 10.3978/j.issn.2072-1439.2014.07.33

Figure 3.

Figure 3

Meta-analysis on disease control rate among advanced NSCLC patients receiving first-line chemotherapy according to EGFR mutation status. NSCLC, non-small-cell lung cancer; EGFR, epidermal growth factor receptor; CI, confidence interval; I2, inconsistency statistic.